本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

5.68
-0.1550-2.66%
成交量:6.13万
成交额:35.26万
市值:3,469.87万
市盈率:-0.27
高:6.00
开:5.87
低:5.54
收:5.83
数据加载中...
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/22

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/25

重要事件披露

Form 8-K - Current report
2023/11/23

SEC问询函

Form CORRESP - Correspondence